PTLA
Neuberger Berman Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-100,000
| Closed | -$2.39M | – | 1651 |
|
|
2019
Q4 | $2.39M | Sell |
100,000
-10,000
| -9% | -$239K | ﹤0.01% | 993 |
|
|
2019
Q3 | $2.95M | Sell |
110,000
-17,900
| -14% | -$480K | ﹤0.01% | 935 |
|
|
2019
Q2 | $3.47M | Buy |
127,900
+57,900
| +83% | +$1.57M | ﹤0.01% | 923 |
|
|
2019
Q1 | $2.43M | Buy |
+70,000
| New | +$2.43M | ﹤0.01% | 944 |
|
|
2018
Q1 | – | Sell |
-23,514
| Closed | -$1.15M | – | 1774 |
|
|
2017
Q4 | $1.15M | Buy |
23,514
+500
| +2% | +$24.3K | ﹤0.01% | 1158 |
|
|
2017
Q3 | $1.24M | Buy |
23,014
+18,343
| +393% | +$991K | ﹤0.01% | 1087 |
|
|
2017
Q2 | $262K | Buy |
+4,671
| New | +$262K | ﹤0.01% | 1442 |
|
|
2015
Q2 | – | Sell |
-30,200
| Closed | -$1.15M | – | 1640 |
|
|
2015
Q1 | $1.15M | Buy |
30,200
+8,281
| +38% | +$314K | ﹤0.01% | 1190 |
|
|
2014
Q4 | $620K | Sell |
21,919
-1,950
| -8% | -$55.2K | ﹤0.01% | 1310 |
|
|
2014
Q3 | $603K | Buy |
+23,869
| New | +$603K | ﹤0.01% | 1334 |
|